regelmäßiger Einnahme von Aspirin reduzierte
in einer in Mailand durchgeführten Studie die Häufigkeit bestimmter
Krebserkrankungen um 2/3.
Aspirin Cuts Cancer Risk by Two Thirds
[Wednesday, March 05, 2003] Chances are good that you have a potent
cancer fighter in your medicine cabinet. Known to protect against
heart disease and thought to protect against bowel and lung cancer,
Aspirin also appears to dramatically cut the risk of mouth, throat
and esophagus cancer.
"This is the first quantitative evidence that taking Aspirin
may reduce the risk of developing cancers in what we call the
aerodigestive tract, connecting the mouth and the stomach,"
says Cristina Bosetti from the Institute of Pharmacological
Research in Milan.
A study led by Bosetti found that that taking Aspirin regularly
for five years cuts the risk of developing such cancers by two
She and colleagues analyzed three separate studies involving 965
cancer patients and 1779 people in hospital for other
The patients provided information on their smoking habits, drinking
habits and daily intake of Aspirin. Those taking the drug were
doing so because of other health problems, such as heart disease.
People who took Aspirin regularly for at least five years had
two thirds less chance of developing cancers of the aerodigestive
"We think that Aspirin may take
effect by acting on an enzyme called cyclooxegenase-2, which has
a role both in inflammation and the process of cancer growth,"
Experts say that before recommending daily Aspirin for everyone,
further research is necessary to evaluate the efficacy and side-effects
of long-term use.
The study was published in the British Journal of Cancer.